August 09, 2023 (Earnings Report)Dear Reader,We just identified several stocks that are expected to release earnings very soon.If you are interested in any of these companies, we encourage you to do your own research and due diligence before pursuing any investments.Keep in mind, the actual earnings date and time may change, so if you’re interested in any of these companies you will need to pay close attention to their announcements.
Novo Nordisk
Symbol: NVO
Recent Price: $189.17
Average Analyst Price Target: (-8.02%)
Market Cap: $347.95B
Last Year's EPS: 6.02
Consensus EPS Forecast: 1.27
Expected Earnings Date: 2023-05-04
Recent Analyst Action: Sachin Jain, analyst at Bank of America Securities, reiterates coverage on Novo Nordisk (NVO) in the Healthcare sector with a Buy rating and a price target of $174 (2 months ago).
TipRanks.com also reports that Novo Nordisk currently has analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is . The target pricing ranges from a high forecast of down to a low forecast of . Novo Nordisk (NVO)’s last closing price was $189.17 which would put the average price target at -8.02% upside.Here are 3rd party ratings for NVO:
- TipRanks.com: Moderate Buy
- TradingView.com:
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: Strong buy
- Zacks.com: Buy, Top 28% (71 out of 250)
--------------------------------------------------------------------------
Brookfield Corporation
Symbol: BN
Recent Price: $33.20
Average Analyst Price Target: (40.90%)
Market Cap: $54.05B
Last Year's EPS: -0.23
Consensus EPS Forecast: 0.68
Expected Earnings Date: 2023-05-11
Recent Analyst Action: Cherilyn Radbourne, analyst at TD Securities, reiterates coverage on Brookfield Corporation (BN) in the Real Estate sector with a Buy rating and a price target of $60 (18 hours ago).
TipRanks.com also reports that Brookfield Corporation currently has analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is . The target pricing ranges from a high forecast of down to a low forecast of . Brookfield Corporation (BN)’s last closing price was $33.20 which would put the average price target at 40.90% upside.Here are 3rd party ratings for BN:
- TipRanks.com: Strong Buy
- TradingView.com:
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: Weak buy
- Zacks.com: n/a, n/a
--------------------------------------------------------------------------
Golar LNG
Symbol: GLNG
Recent Price: $24.14
Average Analyst Price Target: $35.00 (32.56%)
Market Cap: $2.60B
Last Year's EPS: n/a
Consensus EPS Forecast: 1.19
Expected Earnings Date: 2023-05-30
Recent Analyst Action: Benjamin Nolan, analyst at Stifel Nicolaus, reiterates coverage on Golar LNG (GLNG) in the Energy sector with a Buy rating and a price target of $34 (1 month ago).
TipRanks.com also reports that Golar LNG currently has 14 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $35.00 . The target pricing ranges from a high forecast of $35.00 down to a low forecast of $35.00. Golar LNG (GLNG)’s last closing price was $24.14 which would put the average price target at 32.56% upside.Here are 3rd party ratings for GLNG:
- TipRanks.com: Moderate Buy
- TradingView.com:
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: Strong buy
- Zacks.com: Strong Sell, Bottom 21% (197 out of 250)
--------------------------------------------------------------------------
89bio
Symbol: ETNB
Recent Price: $15.59
Average Analyst Price Target: (137.33%)
Market Cap: $1.18B
Last Year's EPS: -1.3
Consensus EPS Forecast: -0.56
Expected Earnings Date: 2023-05-04
Recent Analyst Action: Justin Zelin, analyst at BTIG, reiterates coverage on 89bio (ETNB) in the Healthcare sector with a Buy rating and a price target of $37 (1 month ago).
TipRanks.com also reports that 89bio currently has analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is . The target pricing ranges from a high forecast of down to a low forecast of . 89bio (ETNB)’s last closing price was $15.59 which would put the average price target at 137.33% upside.Here are 3rd party ratings for ETNB:
- TipRanks.com: Strong Buy
- TradingView.com:
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: Weak sell
- Zacks.com: Hold, Top 40% (101 out of 250)
--------------------------------------------------------------------------
Silvercorp Metals
Symbol: SVM
Recent Price: $2.71
Average Analyst Price Target: (136.53%)
Market Cap: $509.87M
Last Year's EPS: 0.07
Consensus EPS Forecast: 0.03
Expected Earnings Date: 2023-05-25
Recent Analyst Action: Gabriel Gonzalez, analyst at Echelon Wealth Partners, reiterates coverage on Silvercorp Metals (SVM) in the Basic Materials sector with a Buy rating and a price target of $5.98 (3 weeks ago).
TipRanks.com also reports that Silvercorp Metals currently has analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is . The target pricing ranges from a high forecast of down to a low forecast of . Silvercorp Metals (SVM)’s last closing price was $2.71 which would put the average price target at 136.53% upside.Here are 3rd party ratings for SVM:
- TipRanks.com: Strong Buy
- TradingView.com:
- Yahoo! Finance: Bearish Short-Term Outlook
- Barchart.com: Strong sell
- Zacks.com: Hold, Bottom 19% (203 out of 250)
--------------------------------------------------------------------------
Aldeyra Therapeutics
Symbol: ALDX
Recent Price: $7.44
Average Analyst Price Target: $26.00 (182.26%)
Market Cap: $470.52M
Last Year's EPS: -0.27
Consensus EPS Forecast: 0.31
Expected Earnings Date: 2023-08-04
Recent Analyst Action: Matthew Caufield, analyst at H.C. Wainwright, reiterates coverage on Aldeyra Therapeutics (ALDX) in the Healthcare sector with a Buy rating and a price target of $15 (1 month ago).
TipRanks.com also reports that Aldeyra Therapeutics currently has 15 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $26.00 . The target pricing ranges from a high forecast of $26.00 down to a low forecast of $26.00. Aldeyra Therapeutics (ALDX)’s last closing price was $7.44 which would put the average price target at 182.26% upside.Here are 3rd party ratings for ALDX:
- TipRanks.com: Strong Buy
- TradingView.com:
- Yahoo! Finance: Bearish Short-Term Outlook
- Barchart.com: sell
- Zacks.com: Hold, Top 34% (84 out of 250)
--------------------------------------------------------------------------
Senseonics Holdings
Symbol: SENS
Recent Price: $0.82
Average Analyst Price Target: $3.00 (1661.42%)
Market Cap: $407.94M
Last Year's EPS: 0.02
Consensus EPS Forecast: -0.025
Expected Earnings Date: 2023-05-09
Recent Analyst Action: Matthew Taylor, analyst at Jefferies, reiterates coverage on Senseonics Holdings (SENS) in the Healthcare sector with a Sell rating and a price target of $0.5 (2 weeks ago).
TipRanks.com also reports that Senseonics Holdings currently has 17 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $3.00 . The target pricing ranges from a high forecast of $3.00 down to a low forecast of $3.00. Senseonics Holdings (SENS)’s last closing price was $0.82 which would put the average price target at 1661.42% upside.Here are 3rd party ratings for SENS:
- TipRanks.com: Hold
- TradingView.com:
- Yahoo! Finance: Bearish Short-Term Outlook
- Barchart.com: Weak sell
- Zacks.com: Hold, Top 36% (89 out of 250)
--------------------------------------------------------------------------
To Your Financial Future,
The Editor, WallStreetSectors.com
